The pivotal role of astrocytes in an in vitro stroke model of the blood-brain barrier

Frontiers in Cellular Neuroscience

Volumn 8, Issue October, 2014, Pages

  Neuhaus, Winfried ^a,b   Gaiser, Fabian ^b   Mahringer, Anne ^c   Franz, Jonas ^d   Riethmüller, Christoph ^d   Förster, Carola ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d Serend IP GmbH   (Germany)

Author keywords

Blood brain barrier; C6; CerebEND; In vitro; Ischemia; Oxygen glucose deprivation; Stroke; Traumatic brain injury

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CLAUDIN 12; CLAUDIN 3; CLAUDIN 5; FLUORESCEIN; GELATINASE A; GELATINASE B; MEMBRANE PROTEIN; MESSENGER RNA; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 4; MULTIDRUG RESISTANCE PROTEIN 1; OCCLUDIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN ZO1; PROTEINASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ASSAY; ASTROCYTE; ATOMIC FORCE MICROSCOPY; BLOOD BRAIN BARRIER; BLOOD CELL; BLOOD FLOW; BRAIN DAMAGE; BRAIN PERICYTE; CELL CULTURE; CELL LINE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE MODEL; DOWN REGULATION; ELECTRIC RESISTANCE; ENDOTHELIUM CELL; ENZYME ACTIVITY; FILTERS AND MEMBRANES; IMMUNOFLUORESCENCE MICROSCOPY; IN VITRO STUDY; ISCHEMIA; MICROGLIA; MOUSE; NONHUMAN; OLIGODENDROGLIA; OXYGEN GLUCOSE DEPRIVATION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS REGULATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84908375551     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2014.00352     Document Type: Article

References (66)

1. Abbott, N. J., Ronnback, L., and Hansson, E. (2006). Astrocyte-endothelial interactions at theblood-brainbarrier. Nat.Rev.Neurosci. 7, 41–53.doi: 10.1038/nrn1824
2. Adibhatla, R. M., and Hatcher, J. F. (2008). Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: therapeutic strategies. CNS Neurol. Disord. Drug Targets 7, 243-253. doi: 10.2174/187152708784936608.
3. Andras, I. E., Deli, M. A., Veszelka, S., Hayashi, K., Hennig, B., and Toborek, M. (2007). The NMDA and AMPA/KA receptors are involved in glutamate-induced alterations of occludin expression and phosphorylation in brain endothelial cells. J. Cereb. Blood Flow Metab. 27, 1431-1443. doi: 10.1038/sj.jcbfm.9600445.
4. Ballabh, P., Braun, A., and Nedergaard, M. (2004). The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol. Dis. 16, 1-13. doi: 10.1016/j.nbd.2003.12.016.
5. Bauer, A. T., Burgers, H. F., Rabie, T., and Marti, H. H. (2010). Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement. J. Cereb. Blood Flow Metab. 30, 837-848. doi: 10.1038/jcbfm.2009.248.
6. Berezowski, V., Fukuda, A. M., Cecchelli, R., andBadaut, J. (2012). Endothelial cells and astrocytes: a concerto en duo in ischemic pathophysiology. Int. J. Cell. Biol. 2012:176287. doi: 10.1155/2012/176287.
7. Berezowski, V., Landry, C., Dehouck, M. P., Cecchelli, R., and Fenart, L. (2004). Contribution of glial cells and pericytes to the mRNA profiles of P-glycoprotein and multidrug resistance-associated proteins in an in vitro model of the blood- brain barrier. Brain Res. 1018, 1-9. doi: 10.1016/j.brainres.2004.05.092.
8. Boveri, M., Berezowski, V., Price, A., Slupek, S., Lenfant, A. M., Benaud, C., et al. (2005). Induction of blood-brain barrier properties in cultured brain capillary endothelial cells: comparison between primary glial cells and C6 cell line. Glia 51, 187-198. doi: 10.1002/glia.20189.
9. Brightman, M. W., and Reese, T. S. (1969). Junctions between initimately apposed cell membranes in the vertebrate brain. J. Cell. Biol. 40, 648-677. doi: 10.1083/jcb.40.3.648.
10. Brillault, J., Berezowski, V., Cecchelli, R., and Dehouck, M. P. (2002). Intercommunications between brain capillary endothelial cells and glial cells increase the transcellular permeability of the blood-brain barrier during ischaemia. J. Neurochem. 83, 807-817. doi: 10.1046/j.1471-4159.2002.01186.x
11. Brouns, R., Wauters, A., De Surgeloose, D., Marien, P., and De Deyn, P. P. (2011). Biochemical markers for blood-brain barrier dysfunction in acute ischemic stroke correlate with evolution and outcome. Eur Neurol. 65, 23-31. doi: 10.1159/000321965.
12. Cecchelli, R., Berezowski, V., Lundquist, S., Culot, M., Renftel, M., Dehouck, M. P., et al. (2007). Modelling of the blood-brain barrier in drug discovery and development. Nat. Rev. DrugDiscov. 6, 650-661. doi: 10.1038/nrd2368.
13. Ceruti, S., Colombo, L., Magni, G., Vigano, F., Boccazzi, M., Deli, M. A., et al. (2011). Oxygen-glucose deprivation increases the enzymatic activity and the microvesicle-mediated release of ectonucleotidases in the cells composing the blood-brain barrier. Neurochem. Int. 59, 259-271. doi: 10.1016/j.neuint.2011.05.013.
14. Culot, M., Lundquist, S., Vanuxeem, D., Nion, S., Landry, C., Delplace, Y., et al. (2008). An in vitro blood-brain barrier model for high throughput (HTS) toxi-cological screening. Toxicol In Vitro 22, 799-811. doi: 10.1016/j.tiv.2007.12.016.
15. Cunningham, L. A., Wetzel, M., and Rosenberg, G. A. (2005). Multiple roles for MMPs and TIMPs in cerebral ischemia. Glia 50, 329-339. doi: 10.1002/glia.20169.
16. Dazert, P., Suofu, Y., Grube, M., Popa-Wagner, A., Kroemer, H. K., Jedlitschky, G., et al. (2006). Differential regulation of transport proteins in the periinfarct region following reversible middle cerebral artery occlusion in rats. Neuroscience 142, 1071-1079. doi: 10.1016/j.neuroscience.2006.07.056.
17. Deli, M. A., and Joo, F. (1996). Culturedvascular endothelial cells of the brain. Keio J. Med. 45, 183-198. doi: 10.2302/kjm.45.183.
18. Doyle, K. P., Cekanaviciute, E., Mamer, L. E., and Buckwalter, M. S. (2010). TGFp signaling in the brain increases with aging and signals to astrocytes and innate immune cells in the weeks after stroke. J. Neuroinflammation 7:62. doi: 10.1186/1742-2094-7-62.
19. El Hafny, B., Chappey, O., Piciotti, M., Debray, M., Boval, B., and Roux, F. (1997). Modulation of P-glycoprotein activity by glial factors and retinoic acid in an immortalized rat brain microvessel endothelial cell line. Neurosci. Lett. 236, 107-111. doi: 10.1016/S0304-3940(97)00679-4.
20. Engelhardt, S., Al-Ahmad, A. J., Gassmann, M., and Ogunshola, O. O. (2014). Hypoxia Selectively Disrupts Brain Microvascular Endothelial Tight Junction Complexes Through a Hypoxia-Inducible Factor-1 (HIF-1) Dependent Mechanism. J. Cell. Physiol. 229, 1096-1105. doi: 10.1002/jcp.24544.
21. Gaillard, P. J., van der Sandt, I. C., Voorwinden, L. H., Vu, D., Nielsen, J. L., de Boer, A. G., et al. (2000). Astrocytes increase the functional expression of P-glycoprotein in an in vitro model of the blood-brain barrier. Pharm. Res. 17, 1198-1205. doi: 10.1023/A:1026406528530.
22. Janzer, R. C., and Raff, M. C. (1987). Astrocytes induce blood-brain barrier properties in endothelial cells. Nature 325, 253-257. doi: 10.1038/325253a0.
23. Jiao, H., Wang, Z., Liu, Y., Wang, P., and Xue, Y. (2011). Specific role of tight junction proteins claudin-5, occludin, and ZO-1 of the blood-brain barrier in a focal cerebral ischemic insult. J. Mol. Neurosci. 44,130-139. doi: 10.1007/s12031-011-9496-4.
24. Jin, R., Yang, G., and Li, G. (2010). Molecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activator. Neurobiol. Dis. 38, 376-385. doi: 10.1016/j.nbd.2010.03.008.
25. Joo, F. (1996). Endothelial cells of the brain and other organ systems: some similarities and differences. Prog. Neurobiol. 48, 255-273. doi: 10.1016/0301-0082(95)00046-1.
26. Jungmann, P., Wilhelmi, M., Oberleithner, H., and Riethmuller, C. (2008). Bradykinin does not induce gap formation between human endothelial cells. Pflugers Arch. 455, 1007-1016. doi: 10.1007/s00424-007-0352-x
27. Kleinschnitz, C., Blecharz, K., Kahles, T., Schwarz, T., Kraft, P., Gobel, K., et al. (2011). Glucocorticoid insensitivity at the hypoxic blood-brain barrier can be reversed by inhibition of the proteasome. Stroke 42, 1081-1089. doi: 10.1161/STROKEAHA.110.592238.
28. Krafft, P. R., Caner, B., Klebe, D., Rolland, W. B., Tang, J., and Zhang, J. H. (2013). PHA-543613 preserves blood-brain barrier integrity after intracerebral hemor¬rhage in mice. Stroke 44, 1743-1747. doi: 10.1161/STROKEAHA.111.000427.
29. Lau, L. T., and Yu, A. C. (2001). Astrocytes produce and release interleukin- 1, interleukin-6, tumor necrosis factor alpha and interferon-gamma fol¬lowing traumatic and metabolic injury. J. Neurotrauma 18, 351-359. doi: 10.1089/08977150151071035.
30. Lazarowski, A., Caltana, L., Merelli, A., Rubio, M. D., Ramos, A. J., and Brusco, A. (2007). Neuronal mdr-1 gene expression after experimental focal hypoxia: a new obstacle for neuroprotection? Neuropathol. Appl. Neurobiol. 35, 147-155. doi: 10.1016/j.jns.2007.03.004.
31. Lee, S. R., Guo, S. Z., Scannevin, R. H., Magliaro, B. C., Rhodes, K. J., Wang, X., et al. (2007). Induction of matrix metalloproteinase, cytokines and chemokines in rat cortical astrocytes exposed to plasminogen activators. Neurosci Lett. 417, 1-5. doi: 10.1016/j.neulet.2007.01.017.
32. Lenglet, S., Montecucco, F., Mach, F., Schaller, K., Gasche, Y., and Copin, J. C. (2014). Analysis of the expression of nine secreted matrix metalloproteinases and their endogenous inhibitors in the brain of mice subjected to ischaemic stroke. Thromb. Haemost. 112, 363-378. doi: 10.1160/TH14-01-0007.
33. Lundquist, S., Renftel, M., Brillault, J., Fenart, L., Cecchelli, R., and Dehouck, M. P. (2002). Prediction of drug transport through the blood-brain barrier in vivo: a comparison between two in vitro cell models. Pharm. Res. 19, 976-981. doi: 10.1023/A:1016462205267.
34. Mathiisen, T. M., Lehre, K. P., Danbolt, N. C., and Ottersen, O. P. (2010). The perivascular astroglial sheath provides a complete covering of the brain microvessels: an electron microscopic 3D reconstruction. Glia 58, 1094-1103. doi: 10.1002/glia.20990.
35. Mysiorek, C., Culot, M., Dehouck, L., Derudas, B., Staels, B., Bordet, R., et al. (2009). Peroxisome-proliferator-activated receptor-alpha activation protects brain capillary endothelial cells from oxygen-glucose deprivation-induced hyperpermeability in the blood-brain barrier. Curr. Neurovasc. Res. 6, 181-193. doi: 10.2174/156720209788970081.
36. Nakagawa, S., Deli, M. A., Kawaguchi, H., Shimizudani, T., Shimono, T., Kittel, A., et al. (2009). A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes. Neurochem. Int. 54, 253-263. doi: 10.1016/j.neuint.2008.12.002.
37. Neuhaus, J., Risau, W., and Wolburg, H. (1991). Induction of blood-brain bar¬rier characteristics in bovine brain endothelial cells by rat astroglial cells in transfilter coculture. Ann. N.Y. Acad. Sci. 633, 578-580. doi: 10.1111/j.1749-6632.1991.tb15667.x
38. Neuhaus, W., Bogner, E., Wirth, M., Trzeciak, J., Lachmann, B., Gabor, F., et al. (2006). A novel tool to characterize paracellular transport: the APTS-dextran ladder. Pharm. Res. 23, 1491-1501. doi: 10.1007/s11095-006-0256-z
39. Neuhaus, W., Burek, M., Djuzenova, C. S., Thal, S. C., Koepsell, H., Roewer, N., et al. (2012a). Addition of NMDA-receptor antagonist MK801 during oxygen/glucose deprivation moderately attenuates the upregulation of glucose uptake after subsequent reoxygenation in brain endothelial cells. Neurosci. Lett. 506, 44-49. doi: 10.1016/j.neulet.2011.10.045.
40. Neuhaus, W., Plattner, V. E., Wirth, M., Germann, B., Lachmann, B., Gabor, F., et al. (2008). Validation of in vitro cell culture models of the blood-brain bar¬rier: tightness characterization of two promising cell lines. J. Pharm. Sci. 97, 5158-5175. doi: 10.1002/jps.21371.
41. Neuhaus, W., Samwer, F., Kunzmann, S., Muellenbach, R. M., Wirth, M., Speer, C. P., et al. (2012b). Lung endothelial cells strengthen, but brain endothelial cells weaken barrier properties of a human alveolar epithelium cell culture model. Differentiation 84, 294-304. doi: 10.1016/j.diff.2012.08.006.
42. Novakova, I., Subileau, E. A., Toegel, S., Gruber, D., Lachmann, B., Urban, E., et al. (2014). Transport rankings ofnon-steroidal antiinflammatory drugs across blood-brain barrier in vitro models. PLoS ONE 9:e86806. doi: 10.1371/jour-nal.pone.0086806.
43. Patak, P., and Hermann, D. M. (2011). ATP-binding cassette transporters at the blood-brain barrier in ischaemic stroke. Curr. Pharm. Des. 17, 2787-2792. doi: 10.2174/138161211797440195.
44. Pfefferkorn, T., and Rosenberg, G. A. (2003). Closure of the blood-brain bar¬rier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion. Stroke 34, 2025-2030. doi: 10.1161/01.STR.0000083051.93319.28.
45. Piontek, J., Fritzsche, S., Cording, J., Richter, S., Hartwig, J., Walter, M., et al. (2011). Elucidating the principles of the molecular organization of heteropolymeric tight junction strands. Cell. Mol. Life Sci. 68, 3903-3918. doi: 10.1007/s00018-011-0680-z
46. Poller, B., Drewe, J., Krahenbuhl, S., Huwyler, J., and Gutmann, H. (2010). Regulation of BCRP (ABCG2) and P-glycoprotein (ABCB1) by cytokines in a model of the human blood-brain barrier. Cell. Mol. Neurobiol. 30, 63-70. doi: 10.1007/s10571-009-9431-1.
47. Redzic, Z. B., Rabie, T., Sutherland, B. A., and Buchan, A. M. (2013). Differential effects of paracrine factors on the survival of cells of the neurovascular unit during oxygen glucose deprivation. Int. J. Stroke. doi: 10.1111/ijs.12197. [Epub ahead of print].
48. Reichel, V., Klas, J., Fricker, G., and Masereeuw, R. (2010). Fluo-cAMP is trans¬ported by multidrug resistance-associated protein isoform 4 in rat choroid plexus. J. Neurochem. 115,200-208. doi: 10.1111/j.1471-4159.2010.06915.x
49. Ronaldson, P. T., and Davis, T. P. (2012). Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke. Curr. Pharm. Des. 18, 3624-3644. doi: 10.2174/138161212802002625.
50. Shin, J. A., Kim, Y. A., Jeong, S. I., Lee, K. E., Kim, H. S., and Park, E. M. (2013). Extracellular signal-regulated kinase1/2-dependent changes in tight junctions after ischemic preconditioning contributes to tolerance induction after ischemic stroke. Brain Struct. Funct. doi: 10.1007/s00429-013-0632-5. [Epub ahead of print].
51. Silwedel, C., and Forster, C. (2006). Differential susceptibility of cerebral and cerebellar murine brain microvascular endothelial cells to loss of barrier prop¬erties in response to inflammatory stimuli. J. Neuroimmunol. 179, 37-45. doi: 10.1016/j.jneuroim.2006.06.019.
52. Spudich, A., Kilic, E., Xing, H., Kilic, U., Rentsch, K. M., Wunderli-Allenspach, H., et al. (2006). Inhibition of multidrug resistance transporter-1 facilitates neuro- protective therapies after focal cerebral ischemia. Nat. Neurosci. 9, 487-488. doi: 10.1038/nn1676.
53. Strecker, J. K., Minnerup, J., Gess, B., Ringelstein, E. B., Schabitz, W. R., and Schilling, M. (2011). Monocyte chemoattractant protein-1-deficiency impairs the expression of IL-6, IL-1p and G-CSF after transient focal ischemia in mice. PLoS ONE 6:e25863. doi: 10.1371/journal.pone.0025863.
54. Takeshita, T., Nakagawa, S., Tatsumi, R., So, G., Hayashi, K., Tanaka, K., et al. (2014). Cilostazol attenuates ischemia-reperfusion-induced blood-brain barrier dysfunction enhanced by advanced glycation endproducts via transforming growth factor-^1 signaling. Mol. Cell. Neurosci. 60C, 1-9. doi: 10.1016/j.mcn.2014.01.006.
55. Thal, S. C., Schaible, E. V., Neuhaus, W., Scheffer, D., Brandstetter, M., Engelhard, K., et al. (2013). Inhibition of proteasomal glucocorticoid receptor degradation restores dexamethasone-mediated stabilization of the blood-brain barrier after traumatic brain injury. Crit. Care Med. 41, 1305-1315. doi: 10.1097/CCM.0b013e31827ca494.
56. Thoelking, G., Reiss, B., Wegener, J., Oberleithner, H., Pavenstaedt, H., and Riethmuller, C. (2010). Nanotopographyfollows force in TGF-beta1 stimulated epithelium. Nanotechnology 21, 265102. doi: 10.1088/0957-4484/21/26/265102.
57. Török, M., Huwyler, J., Gutmann, H., Fricker, G., and Drewe, J. (2003). Modulation of transendothelial permeability and expression of ATP-binding cassette transporters in cultured brain capillary endothelial cells by astrocytic factors and cell-culture conditions. Exp. Brain Res. 153, 356-365. doi: 10.1007/s00221-003-1620-4.
58. Tsuji, K., Aoki, T., Tejima, E., Arai, K., Lee, S. R., Atochin, D. N., et al. (2005). Tissue plasminogen activator promotes matrix metalloproteinase- 9 upregulation after focal cerebral ischemia. Stroke 36, 1954-1959. doi: 10.1161/01.STR.0000177517.01203.eb
59. Ueno, M., Nakagawa, T., Huang, C. L., Ueki, M., Kusaka, T., Hosomi, N., et al. (2009). The expression ofP-glycoprotein is increased in vessels with blood-brain barrier impairment in a stroke-prone hypertensive model. Neuropathol. Appl. Neurobiol. 35, 147-155. doi: 10.1111/j.1365-2990.2008.00966.x
60. Vangilder, R. L., Rosen, C. L., Barr, T. L., and Huber, J. D. (2011). Targeting the neurovascular unit for treatment of neurological disorders. Pharmacol. Ther. 130, 239-247. doi: 10.1016/j.pharmthera.2010.12.004.
61. Wang, Y. F., Tsirka, S. E., Strickland, S., Stieg, P. E., Soriano, S. G., and Lipton, S. A. (1998). Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nat. Med. 4, 228-231. doi: 10.1038/nm0298-228.
62. Willis, C. L., Camire, R. B., Brule, S. A., and Ray, D. E. (2013). Partial recovery of the damaged rat blood-brain barrier is mediated by adherens junction complexes, extracellular matrix remodeling and macrophage infiltration following focal astrocyte loss. Neuroscience 250, 773-785. doi: 10.1016/j.neuroscience.2013.06.061.
63. Willis, C. L., Leach, L., Clarke, G. J., Nolan, C. C., and Ray, D. E. (2004). Reversible disruption of tight junction complexes in the rat blood-brain barrier, following transitoryfocal astrocyte loss. Glia 48, 1-13. doi: 10.1002/glia.20049.
64. Witt, K. A., Mark, K. S., Hom, S., and Davis, T. P. (2003). Effects of hypoxia- reoxygenation on rat blood-brain barrier permeability and tight junctional protein expression. Am. J. Physiol. Heart Circ. Physiol. 285, H2820-H2831. doi: 10.1152/ajpheart.00589.2003.
65. Yang, Y., and Rosenberg, G. A. (2011). Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke 42, 3323-3328. doi: 10.1161/STROKEAHA.110.608257.
66. Yeh, W. L., Lin, C. J., and Fu, W. M. (2008). Enhancement of glucose transporter expression of brain endothelial cells by vascular endothelial growth factor derived from glioma exposed to hypoxia. Mol. Pharmacol. 73, 170-177. doi: 10.1124/mol.107.038851